Fluorescent compounds

• US 9,097,667 B2
• Filed: 12/12/2008
• Issued: 08/04/2015
• Est. Priority Date: 12/14/2007
• Status: Active Grant

• Current Assignee: Biotium, Inc.
• Original Assignee: Biotium, Inc.
• Inventors: Mao, Fei, Leung, Wai-Yee, Cheung, Ching-Ying, Hoover, Hye Eun
• Primary Examiner(s): Otton, Alicia L
• Application Number:
  US12/334,387
• Publication Number:
  US 20090305410A1
• Time in Patent Office: 2,426 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: C09B 11/08 Phthaleins; Phenolphthaleins; Fluorescein
• CPC Class Codes: C09B 11/24 Phthaleins containing amino groups ; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes
• CPC Class Codes: C09B 23/0066 the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
• CPC Class Codes: C09B 23/06 three >CH- groups, e.g. carbocyanines
• CPC Class Codes: C09B 23/083 five >CH- groups
• CPC Class Codes: C09B 23/086 more than five >CH- groups
• CPC Class Codes: C09B 57/001 Pyrene dyes
• CPC Class Codes: C09B 57/02 Coumarine dyes
• CPC Class Codes: C09B 69/00 Dyes not provided for by a single group of this subclass
• CPC Class Codes: G01N 2021/6439 with indicators, stains, dyes, tags, labels, marks
• CPC Class Codes: G01N 21/6428 Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" in vivo A61B5/00; immunoassay G01N33/53
• CPC Class Codes: G01N 33/582 with fluorescent label

Abstract

The present invention relates to fluorescent dyes. The present invention provides a wide range of fluorescent dyes and kits containing the same, which are applicable for labeling a variety of biomolecules, cells and microorganisms. In one aspect, the invention provides a compound having a maximal fluorescence excitation wavelength, wherein the compound has a structure of Formula II:
F—Y=Ψ  Formula II
and wherein Z— is a counterion, Y is a bridge unit permitting electron delocalization between F and Ψ, and F is a moiety having the structure:

The present invention also provides various methods of using the fluorescent dyes for research and development, forensic identification, environmental studies, diagnosis, prognosis, and/or treatment of disease conditions.

Claims

1. A compound of any one of the formulae:

2. A kit comprising:

i) the compound of claim 1;

ii) a buffer;

iii) materials or devices for purifying conjugation products; and

iv) instructions instructing the use of the compound.

3. A biomolecule having an amine, a thiol, a hydroxyl, or an aldehyde functional group comprising a label having a structure of a Formula of claim 1, wherein the at least one reactive moiety of the Formula has undergone a reaction which attaches the label to the biomolecule.

4. The biomolecule comprising a label of claim 3 wherein the biomolecule comprises a polynucleotide.

5. The biomolecule comprising a label of claim 3 wherein the biomolecule comprises a polypeptide.

6. The biomolecule of claim 5, wherein the polypeptide further comprises an antigen binding site.

7. The biomolecule of claim 5, wherein the polypeptide is a whole immunoglobulin.

8. The biomolecule of claim 5, wherein the polypeptide is a Fab fragment.

9. An immunoglobulin having an amine, a thiol, a hydroxyl, or an aldehyde functional group labeled with a compound of claim 1.

10. The immunoglobulin of claim 9, wherein the immunoglobulin retains binding specificity to a target upon conjugation to the fluorescent compound.

11. The immunoglobulin of claim 10, wherein the immunoglobin is an antibody that binds specifically to an antigen on a cancer cell.

12. The immunoglobin of claim 11 wherein the antibody binds to erb2.

13. An immunoglobin having an amine, a thiol, a hydroxyl, or an aldehyde functional group comprising a label having a structure of a Formula of claim 1 wherein the at least one reactive moiety of the Formula has undergone a reaction which attaches the label to the immunoglobin, wherein the immunoglobin is an antibody that binds specifically to an antigen on a cancer cell.

14. The immunoglobin of claim 13 wherein the antibody binds to erb2.

15. A polypeptide having an amine, a thiol, a hydroxyl, or an aldehyde functional group labeled with a fluorescent compound, the polypeptide exhibiting a serum half-life no shorter than that of a corresponding polypeptide that lacks the fluorescent compound, wherein the fluorescent compound is a compound of claim 1.

16. A method of preparing a labeled biomolecule comprising reacting a compound of claim 1 and a substrate biomolecule under conditions sufficient to effect crosslinking between the compound and the substrate biomolecule.

17. The method of claim 16, wherein the substrate biomolecule is a polypeptide, a polynucleotide, a carbohydrate, a lipid or a combination thereof.

18. The method of claim 17, wherein the substrate biomolecule is a polynucleotide.

19. A method of labeling a polypeptide comprising:

forming a complex that comprises the polypeptide and a binding agent, wherein the binding agent comprises a fluorescent label having a structure of formula of claim 1 wherein the at least one reactive moiety of the Formula has undergone a reaction which attaches the label to the binding agent.

20. The method of claim 19 wherein the binding agent is an antibody.

21. The method of claim 20 wherein the complex comprises (a) a primary antibody that binds to the polypeptide, and (b) the binding agent which functions as a secondary antibody exhibiting binding capability to the primary antibody.

22. The method of claim 21, wherein the labeling occurs on a solid substrate.

23. The method of claim 21 that labels a polypeptide intracellularly.

24. The method of claim 21, wherein the complex yields a signal to noise ratio greater than about 100, wherein the signal to noise ratio is calculated by the formula:

(fluorescent signal from a complex comprising the polypeptide bound by a primary antibody which in turn is bound to the binding agent)/(fluorescent signal from a mixture of the polypeptide, an isotype control primary antibody and the binding agent).

25. The method of claim 21, wherein the complex yields a signal to noise ratio greater than about 250, wherein the signal to noise ratio is calculated by the formula:

(fluorescent signal from a complex comprising the polypeptide bound by a primary antibody which in turn is bound to the binding agent)/(fluorescent signal from a mixture of the polypeptide, an isotype control primary antibody and the binding agent).

26. The method of claim 21, wherein the complex yields a signal to noise ratio greater than about 270, wherein the signal to noise ratio is calculated by the formula:

(fluorescent signal from a complex comprising the polypeptide bound by a primary antibody which in turn is bound to the binding agent)/(fluorescent signal from a mixture of the polypeptide, an isotype control primary antibody and the binding agent).

27. A method for labeling a cell within a population of cells whereby the cell is differentially labeled relative to neighboring cells within the population, the method comprising contacting the cell with a biomolecule of claim 3, wherein the biomolecule comprises a targeting moiety that binds to a binding partner that is indicative of the cell, and thereby differentially labeling the cell relative to neighboring cells within the population.

28. The method of claim 27, further comprising the step of imaging the cell, the imaging step comprising:

i) directing exciting wavelength to the cell; and

ii) detecting emitted fluorescence from the cell.

29. The method of claim 27, wherein the labeling takes place in vitro.

30. The method of claim 27, wherein the labeling takes place in vivo.